Clinical Trial

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

Study acronym: OPTIMA-C
Recruiting
View on ClinicalTrials.gov →
Summary
The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty. In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-10-04.
Status change: Not Yet Recruiting → Recruiting 2025-04-08
Trial Details
NCT Number NCT06073106
Lead Sponsor Tan Tock Seng Hospital
Collaborators: Rehabilitation Research Institute of Singapore (RRIS), Woodlands Health (WH)
Conditions Stroke, Traumatic Brain Injury, Knee Osteoarthritis, Breast Cancer
Enrollment 500 participants
Start Date 2025-01-01
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-11